A potential drug target for particle-driven diseases such as gout may be a focus of new treatments, a research team reports in the Journal of Leukocyte Biology. Continue reading
A diet known to reduce the risk of hypertension and cardiovascular disease may also lower the risk of gout, says research published in the British Medical Journal. Continue reading
Experts are developing compounds that could allow the pain-relieving effects of ibuprofen to last longer, they report in Molecular Pharmaceutics. And the approach could also be used to deliver other drugs orally that currently can only be taken intravenously.
Metal-organic frameworks are compounds made of metal ions linked to organic ligands, for drug delivery. Active ingredients can be packed inside the metal organic frameworks. They are porous, and some dissolve in water so are good candidates for drug couriers.
The researchers loaded ibuprofen into metal organic frameworks. The compounds were found to reach the bloodstream (of mice) quickly and lasted for twice as long as ibuprofen salts, which are the active ingredient in liquid gel formulations.
For more in-depth features, interviews and information, subscribe to Arthritis Digest magazine, a popular title that’s published six times a year. Click here for the digital version or tel 0845 643 8470 to order your had copy. You’ll know what your doctor is talking about, what new drugs are in the pipeline and be up to date on helpful products.
The action of gut microorganisms on dietary fibres may reduce inflammation associated with gout, highlights research in the Journal of Leukocyte Biology.
The government must do more to support people with arthritis to work highlights Arthritis Research UK
The government launched a consultation on 31 October 2016 looking at the employment, health and welfare support available for people with disabilities and long-term conditions such as arthritis. Continue reading